A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. [electronic resource]
- Blood Apr 2007
- 3417-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't